Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

by Szarmach J, Cubała WJ, Włodarczyk A, Gałuszko-Węgielnik M
Published 2020-10-01

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study

by Wilkowska A, Włodarczyk A, Gałuszko-Węgielnik M, Wiglusz MS, Cubała WJ
Published 2021-08-01